Home | About | RSS Feed | Contact and Publicity Guidelines | Comment Policy the Law, the Universe, and Everything 

Search


Concurring Opinions is a
general-interest legal blog
operated by Concurring
Opinions LLC, a Pennsylvania
Limited Liability Corporation.

jr_12809_9780195367195_bnr.JPG

ad-logo5.jpg

Our Podcast

Subscribe to Law Talk

law-rev-contents2.jpg


  • Posts by Author

  • Categories

  • Archives


  • Recent Comments

    • Charles Wheeler on Racial Profiling Still Pervasive in United States: Does Anyone Care?

    • Bruce Boyden on Lori Drew Tentatively Acquitted

    • alex on Lori Drew Tentatively Acquitted

    • Dan Culley on Perils of a “Lightly Regulated” Insurance Market

    • Frank Pasquale on Financial Innovation?

    • Robyn A on Lori Drew Tentatively Acquitted

    • Bruce Boyden on Lori Drew Tentatively Acquitted

    • Larry Rosenthal on Truthseeking and Criminal Procedure in the Supreme Court’s Last Term

    • Howard Wasserman on Truthseeking and Criminal Procedure in the Supreme Court’s Last Term

    • Adam on Financial Innovation?

    • Amy on Truthseeking and Criminal Procedure in the Supreme Court’s Last Term

    • cjmajor on Lori Drew Tentatively Acquitted

    • cj on Lori Drew Tentatively Acquitted

    • Howard Wasserman on Truthseeking and Criminal Procedure in the Supreme Court’s Last Term

    • Colin Miller on Truthseeking and Criminal Procedure in the Supreme Court’s Last Term

  •  

    Site Meter

Discriminating Our Way to Universal Health Care

posted by Frank Pasquale

When libertarian bloggers hear about rationing by the British National Health Service, they get quite distressed. But I rarely hear the same level of outrage over stories like this:

One of California’s largest for-profit insurers stopped a controversial practice of canceling sick policyholders Friday after a judge ordered Health Net Inc. to pay more than $9 million to a breast cancer patient it dropped in the middle of chemotherapy. . . . “Health Net was primarily concerned with and considered its own financial interests and gave little, if any, consideration and concern for the interests of the insured,” [a private arbitration judge] wrote in a 21-page ruling. . . . When Health Net dropped her in January 2004, [the patient] was . . . forced to stop chemotherapy for several months until she found a charity to pay for it.

A few years ago, a doctor/novelist (Robin Cook) suggested that private insurers may eventually provoke adoption of a universal health care system if they use new technologies of genetic discrimination to avoid sick patients.


The argument is worth quoting in full, because it points out some deep difficulties in a “market” for private insurance that provides “tailored” policies in response to individual needs:

[A] negative consequence of [a] new ability to predict illness is the potential for discrimination in one form or another if confidential health information is released. Unfortunately the chances of such a breach of privacy occurring, despite lip service by politicians to prevent it legislatively, are probably inevitable. Not only is microarray technology easily accessible, but for-profit private insurance companies have strong incentives to use it to protect their bottom lines by denying service, claims or even coverage.

It is precisely this danger, however, that may lead to a great breakthrough: the inevitable movement to universal health care. In this dawning era of genomic medicine, the result may be that the concept of private health insurance, which is based on actuarially pooling risk within specified, fragmented groups, will become obsolete since risk cannot be pooled if it can be determined for individual policyholders. Genetically determined predilection for disease will become the modern equivalent of the “pre-existing condition” that private insurers have stringently avoided.

As a doctor I have always been against health insurance except for catastrophic care and for the very poor. It has been my experience that the doctor-patient relationship is the most personal and rewarding for both the patient and the doctor when a clear, direct fiduciary relationship exists. In such a circumstance, both individuals value the encounter more, which invariably leads to more time, more attention to potentially important details, and a higher level of patient compliance and satisfaction - all of which invariably result in a better outcome.

But with the end of pooling risk within defined groups, there is only one solution to the problem of paying for health care in the United States: to pool risk for the entire nation. (Under the rubric of health care I mean a comprehensive package that includes preventive care, acute care and catastrophic care.) Although I never thought I’d advocate a government-sponsored, obviously non-profit, tax-supported, universal access, single-payer plan, I’ve changed my mind: the sooner we move to such a system, the better off we will be. Only with universal health care will we be able to pool risk for the entire country and share what nature has dealt us; only then will there be no motivation for anyone or any organization to ferret out an individual’s confidential, genetic makeup.

Cook’s argument is a powerful counternarrative to a dominant theme of “medicine & technology” discourse. Usually, technological advance is Exhibit A for the logic of a tiered medical system–if only the comparatively wealthy can afford something new, it’s fine to allow them to get better technology than others because it incentivizes the development of technology that all can afford. But if technology makes existing markets for private insurance obsolete by rendering risk more transparent, it may well catalyze more egalitarian methods of pooling risk.


 February 23, 2008 at 10:03 pm   Posted in: Health Law, Privacy   Print This Post Print This Post

Responses (5)

  1. Daniel S. Goldberg - February 24, 2008 at 12:43 am

    Note that this award was ordered by an arbitration judge, the importance of which ought not be understated. Nor is it irrelevant that the $9 million in damages were punitive in nature, and that the arbitrator found the insurer breached its duty of good faith and fair dealing (I’m not sure how it is in California, but I practiced insurance law in Texas, and in Texas it’s difficult to satisfy the BOP on this particular duty, meaning that the conduct would have to be quite egregious to prove up this count).

    Perhaps the tort reform proponents urging that consumers are not necessarily worse off in arbitration would endorse this decision?

    The language in the opinion is actually worth quoting here, as its among the most acerbic I’ve seen from an arbitrator, though, admittedly, most arbitration resolutions are not reduced to writing:

    “It’s difficult to imagine a policy more reprehensible than tying bonuses to encourage the rescission of health insurance that keeps the public well and alive.”

    Reprehensible, surely. But it just shows the power the possibility of rents exerts on our behavior. It’s why, again, I query, along with Allen Buchanan, why anyone ever imagined for one solitary second that health insurers are likely to act in ways that allocate resources justly.

  2. KipEsquire - February 24, 2008 at 1:15 am

    Isn’t it interesting that redistributionists once legitimized their views with a “veil of ignorance” and are now legitimizing it with an “anti-veil of knowledge”?

    Whatever it takes, I guess.

  3. Roger Zimmerman - February 26, 2008 at 8:57 am

    To claim that Health Net’s (and the other California insurers) behavior is that of an actor in a free-market system is ludicrous. This is just another example of regulation begetting more regulation. The insurers were using cancellations as a cost control measure in a rigged system - one that forces them to cover a prescribed menu of conditions and prescribed rates if they want to do business. Now they can no longer use that cost control measure, so they will try to find others, such as discriminating as best they can with initial sign ups (though I’m sure this is heavily regulated as well).

    In a free market, insurers could discriminate based on price and coverage, and reach an equilibrium which would offer the widest possible insurance options with the greatest efficiency. Since DNA does not guarantee future health (one way or the other), there would still be some degree of risk which could be shared among those that were not currently sick.

    Would some people be priced out of health insurance? Of course. But at least they would have a viable health care industry to serve their needs as charity cases, in contrast to the slowly decaying monstrosity that would result from the complete nationalization of health care funding.

  4. Frank - February 26, 2008 at 9:05 am

    To Roger Zimmerman: is there any serious politician or policy expert pushing a nationalization model in the U.S.? France, Germany, the Netherlands all provide models for us more compelling than the British NHS…which has itself become more open to private insurance and innovation.

    Taiwan provides yet another model:

    http://dissentmagazine.org/article/?article=985

    “The provision of health care is not nationalized, despite a degree of information and coordination that, for example, the British system cannot match after spending billions on computerization. Rather, [Taiwan's National Health Insurance Program, introduced in 1995] is a classic single payer scheme—the government runs a compulsory, mostly premium-financed insurance system, which negotiates a single payment schedule with the private and municipal or government-owned providers.”

    “Health care is provided by a competitive mixture of municipal and public (about one-third of the beds) and privately owned hospitals that also offer comprehensive primary care. Between them they employ almost two-thirds of doctors.”

  5. Daniel S. Goldberg - February 26, 2008 at 4:11 pm

    Roger,

    I am unsure I understand your point. Please explain to me how, in a completely free and unfettered market, there exist incentives for insurers to cover seriously ill persons?

    Of course, this could easily be done by simply correlating premiums to the risk level, but that kind of begs the question b/c, as you admit, so many sick persons would be priced out of coverage and thereby excluded from the pool. So I’m having difficulty seeing how this current case is a product of “regulation” rather than the array of incentives in the health insurance industry. Removing all regulation would hardly ameliorate these incentives, nor would it make it likelier that sick persons obtain insurance coverage, if we care about that at all.

    Indeed, premiums are more closely calibrated to individual risk in the individual health insurance market, which is partly why the cost of individual health insurance is exorbitant.

Leave a Reply

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word


  • « Previous post
  • Next post »

Authors

Daniel J. Solove

Website
Understanding Privacy

Kaimipono Wenger

Website
SSRN Page

Dave Hoffman

Website
SSRN Page

Nate Oman

Website
SSRN Page

Frank Pasquale

Website
SSRN Page

Deven Desai

Website
SSRN Page

Michael O'Shea

Website
SSRN Page

Sarah Waldeck

Website
SSRN Page

Lawrence Cunningham

Website
SSRN Page

Danielle Citron

Website
SSRN Page

Jaya Ramji-Nogales

Website
SSRN Page

Solangel Maldonado

Website
SSRN Page

Gerard Magliocca

Website
SSRN Page


Guests

Michael Abramowicz
Robert Hillman
Kevin Johnson
Sarah Lawsky
Robert Percival
Jenia Turner






Previous Guests

Michael Abramowicz
Michelle Adams
Robert Ahdieh
Michelle Anderson
Laura Appleman
Ann Bartow
Francesca Bignami
Jeremy Blumenthal
Bruce Boyden
Donald Braman
Al Brophy
Neil H. Buchanan
Bill Burke-White
Scott Burris
Paul Butler
Naomi Cahn
Anupam Chander
Miriam Cherry
Jack Chin
Jennifer Collins
Allison Danner
Brannon Denning
Deven Desai
Mike Dimino
Mark Edwards
David Fagundes
Christine Haight Farley
Kim Ferzan
Dan Filler
Michael Froomkin
Amanda Frost
Timothy Glynn
Rachel Godsil
Eric Goldman
David Gray
Craig Green
Tristin Green
Jeffrey Harrison
Erica Hashimoto
Carissa Hessick
Laura Heymann
Christine Hurt
Darian Ibrahim
Dan Kahan
Brian Kalt
Sam Kamin
Chimène Keitner
Orin Kerr
Nancy Kim
Heidi Kitrosser
Adam Kolber
Russell Korobkin
Anita S. Krishnakumar
Susan Kuo
Greg Lastowka
Sarah Lawsky
Erik Lillquist
Jeff Lipshaw
Jonathan Lipson
Jacqueline Lipton
Joseph Liu
Michael Madison
Solangel Maldonado
Jason Mazzone
William McGeveran
Salil Mehra
Carrie Menkel-Meadow
Max Minzner
Scott Moss
Eric Muller
Jaya Ramji-Nogales
Helen Norton
Elizabeth Nowicki
Paul Ohm
Michael O'Shea
David Opderback
Kristen Osenga
Rafael Pardo
Marcy Peek
Eduardo Peñalver
David Post
Shruti Rana
Geoffrey Rapp
Neil Richards
Lori Ringhand
Alice Ristroph
Susan Scafidi
Paul Secunda
Jessica Silbey
Peter Smith
Charles Sullivan
Rick Swedloff
Steph Tai
Andrew Taslitz
Robert Tsai
Steve Vladeck
Sarah Waldeck
Melissa Waters
Alfred Yen
David Zaring
Timothy Zick
Howard Wasserman
Frank Wu
Corey Yung
Jonathan Zittrain

Blogroll

Above the Law
ACS Blog
Althouse
Balkinization
Becker-Posner Blog
BlackProf
BoingBoing
Chicago Law Faculty Blog
Conglomerate
CrimLaw
Crime & Federalism
CrimProf Blog
Crooked Timber
Discourse.net
Dorf on Law
Election Law
Emergent Chaos
The Faculty Lounge
Feminist Law Profs
43(B)log
Freakonomics Blog
Freedom to Tinker
Google Blogoscoped
How Appealing
Ideoblog
Info/Law
Instapundit.com
Juris Novus
Jurisdynamics
Law and Humanities Blog
Law and Letters
Law Librarian Blog
Legal Profession Blog
Legal Theory Blog
Legal Times Blog
Leiter Reports
Brian Leiter's Law School Reports
Lessig Blog
Madisonian Theory
Media Law Blog
Mirror of Justice
The Moderate Voice
National Security Advisors
Opinio Juris
Point of Law
PrawfsBlawg
ProfessorBainbridge.com
Property Prof Blog
Red Tape Chronicles
The Right Coast
Schneier on Security
SCOTUSBlog
Security Dilemmas
Sentencing Law and Policy
Simple Justice
Sivacracy.net
The Situationist
Susan Crawford
TalkLeft
Talking Points Memo
TaxProf Blog
Tech & Marketing Law
Truth on the Market
Volokh Conspiracy
WorkPlace Prof Blog
WSJ Law Blog
Wonkette
The Yin Blog


© Concurring Opinions

Powered by WordPress